Literature DB >> 18037274

Ivermectin: 25 years and still going strong.

S Omura1.   

Abstract

Ivermectin is a drug that many people will never have heard of. Yet thousands of villagers of all ages in communities scattered throughout the remotest parts of Africa and Latin America know its name, and some experts regard it as one of the greatest health interventions of the past 50 years. Ivermectin was brought to the commercial market place for multi-purpose use in animal health in 1981. Six years later it was registered for human use. This remarkable compound has improved the lives and productivity of billions of humans, livestock and pets around the globe, and promises to help consign to the history books two devastating and disfiguring diseases that have plagued people throughout the tropics for generations--while new uses for it are continually being found.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037274     DOI: 10.1016/j.ijantimicag.2007.08.023

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  85 in total

Review 1.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

2.  Fate of ivermectin in the terrestrial and aquatic environment: mobility, degradation, and toxicity towards Daphnia similis.

Authors:  Susanne Rath; Leandro Alves Pereira; Sandra Maria Dal Bosco; Milena Guedes Maniero; Anne Hélène Fostier; José Roberto Guimarães
Journal:  Environ Sci Pollut Res Int       Date:  2015-11-18       Impact factor: 4.223

3.  Total synthesis of avermectin B1a revisited.

Authors:  Shuji Yamashita; Daisuke Hayashi; Aoi Nakano; Yujiro Hayashi; Masahiro Hirama
Journal:  J Antibiot (Tokyo)       Date:  2015-09-09       Impact factor: 2.649

4.  Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.

Authors:  Eloise Mastrangelo; Margherita Pezzullo; Tine De Burghgraeve; Suzanne Kaptein; Boris Pastorino; Kai Dallmeier; Xavier de Lamballerie; Johan Neyts; Alicia M Hanson; David N Frick; Martino Bolognesi; Mario Milani
Journal:  J Antimicrob Chemother       Date:  2012-04-25       Impact factor: 5.790

Review 5.  Importance of microbial natural products and the need to revitalize their discovery.

Authors:  Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2013-08-30       Impact factor: 3.346

6.  Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.

Authors:  Mandy Juarez; Alejandro Schcolnik-Cabrera; Guadalupe Dominguez-Gomez; Alma Chavez-Blanco; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-30       Impact factor: 3.333

7.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 8.  Genomic basis for natural product biosynthetic diversity in the actinomycetes.

Authors:  Markus Nett; Haruo Ikeda; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2009-09-01       Impact factor: 13.423

Review 9.  Implication of the purinergic system in alcohol use disorders.

Authors:  Liana Asatryan; Hyung W Nam; Moonnoh R Lee; Mahesh M Thakkar; M Saeed Dar; Daryl L Davies; Doo-Sup Choi
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

10.  Sorption, Leaching, and Surface Runoff of Beef Cattle Veterinary Pharmaceuticals under Simulated Irrigated Pasture Conditions.

Authors:  Inna E Popova; Daniel A Bair; Kenneth W Tate; Sanjai J Parikh
Journal:  J Environ Qual       Date:  2013-07       Impact factor: 2.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.